News
We're partnering with US company Neurolixis to accelerate the development of a drug that could prevent dyskinesia, a debilitating side effect of Parkinson's medication.
A study, featured in the Daily Mail, suggests a link between certain types of flu and risk of Parkinson's.
New figures from Parkinson's UK show that more than 12,000 Scots are now living with Parkinson's, and numbers are continuing to rise.
The number of people diagnosed and living with Parkinson’s is increasing, according to our latest research.
Researchers in Japan have discovered that people with Parkinson's may have lower levels of caffeine in their blood after drinking tea and coffee.
A Parkinson's UK-funded study, inspired by a woman's ability to smell the condition, has resulted in the discovery of 10 molecules which could lead to the first diagnostic test for Parkinson's.
A round-up of our activities with politicians to keep Parkinson's on their agenda.
Research supported by Parkinson's UK has identified a medicine used to treat tapeworm infections which could lead to new treatments for people with Parkinson's.
It's one year on and our Live Loud! volunteers in Wales continue to make a real difference to people whose voices have been affected by Parkinson's.
UK researchers publish further evidence highlighting the need to licence pimavanserin for hallucinations and delusions in Parkinson's.